India has found violations related to manufacturing and laboratory practices at drugmaker Riemann Labs, whose cough syrup was linked to child deaths in Cameroon, a government health official told Reuters on Wednesday. Riemann Labs is the fourth Indian cough syrup maker to stop production after regulators found lapses.
